Screening for membrane hormone receptor expression in primary aldosteronism

European Journal of Endocrinology

Volumn 160, Issue 3, 2009, Pages 443-451

  Zwermann, O ^a   Suttmann, Y ^a   Bidlingmaier, M ^a   Beuschlein, F ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR 1; ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR 1A; ARGIPRESSIN RECEPTOR 2; CORTICOTROPIN; DEXAMETHASONE; G PROTEIN COUPLED RECEPTOR; GLUCAGON RECEPTOR; GLUCOCORTICOID RECEPTOR; GONADORELIN; GONADORELIN RECEPTOR; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE 1; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; METOCLOPRAMIDE; PROTIRELIN; PROTIRELIN RECEPTOR; RECOMBINANT GLUCAGON; RELEFACT; SEROTONIN 4 RECEPTOR; TETRACOSACTIDE; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V2 RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; HORMONE RECEPTOR; MELANOCORTIN 2 RECEPTOR; VASOPRESSIN RECEPTOR;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; BODY POSTURE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOKALEMIA; NUCLEOTIDE SEQUENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ADENOMA; ADRENAL TUMOR; ADULT; AGED; BLOOD; GENETIC SCREENING; GENETICS; HYPERALDOSTERONISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; AGED; ALDOSTERONE; GENETIC SCREENING; HUMANS; HYPERALDOSTERONISM; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, GLUCAGON; RECEPTORS, LH; RECEPTORS, LHRH; RECEPTORS, SEROTONIN, 5-HT4; RECEPTORS, THYROTROPIN; RECEPTORS, THYROTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 62649116540     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0711     Document Type: Article

References (40)

1. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F & Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. Journal of Clinical Endocrinology and Metabolism 2004 89 1045-1050.
2. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC & Mantero F. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. Journal of the American College of Cardiology 2006 48 2293-2300.
3. Conn JW. Primary aldosteronism. Journal of Laboratory and Clinical Medicine 1955 45 661-664.
4. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM & Mahoudeau J. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. New England Journal of Medicine 1992 327 981-986.
5. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. New England Journal of Medicine 1992 327 974-980.
6. Lacroix A, Ndiaye N, Tremblay J & Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Reviews 2001 22 75-110.
7. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P & Lacroix A. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? Journal of Clinical Endocrinology and Metabolism 2000 85 3531-3536.
8. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H & Lefebvre H. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2005 90 1302-1310.
9. Reznik Y, Lefebvre H, Rohmer V, Charbonnel B, Tabarin A, Rodien P, Lecomte P, Bardet S, Coffin C & Mahoudeau J. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clinical Endocrinology 2004 61 311-319.
10. Christopoulos S, Bourdeau I & Lacroix A. Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Hormone Research 2005 64 119-131.
11. Lacroix A, Hamet P & Boutin JM. Leuprolide acetate therapy in luteinizing hormone - dependent Cushing's syndrome. New England Journal of Medicine 1999 341 1577-1581.
12. Bourdeau I, D'Amour P, Hamet P, Boutin JM & Lacroix A. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5534-5540.
13. Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, de Jong FH, Bonjer HJ, Clark AJ, van der Lely AJ & de Herder WW. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. Journal of Clinical Endocrinology and Metabolism 2003 88 230-237.
14. Lacroix A, Tremblay J, Rousseau G, Bouvier M & Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. New England Journal of Medicine 1997 337 1429-1434.
15. Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP & Bornstein SR. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. New England Journal of Medicine 1998 339 27-31.
16. Nakamura Y, Son Y, Kohno Y, Shimono D, Kuwamura N, Koshiyama H, Sasano H & Matsuda T. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II. Endocrine 2001 15 57-61.
17. Arnaldi G, Gasc JM, de Keyzer Y, Raffin-Sanson ML, Perraudin V, Kuhn JM, Raux-Demay MC, Luton JP, Clauser E & Bertagna X. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 2029-2035.
18. Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, Shibata T, Suwa T, Ishizuka T & Yasuda K. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clinical Endocrinology 1998 49 403-409.
19. Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Perraudin V, Bertherat J & Lefebvre H. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. Journal of Endocrinology 2008 196 1-9.
20. Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, Kuhn JM, Lacroix A, Tabarin A, Young J, Vaudry H & Lefebvre H. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 248-254.
21. Mannelli M, Ferruzzi P, Luciani P, Crescioli C, Buci L, Corona G, Serio M & Peri A. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. Journal of Clinical Endocrinology and Metabolism 2003 88 4616-4622.
22. Saner-Amigh K, Mayhew BA, Mantero F, Schiavi F, White PC, Rao CV & Rainey WE. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. Journal of Clinical Endocrinology and Metabolism 2006 91 1136-1142.
23. Ye P, Mariniello B, Mantero F, Shibata H & Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. Journal of Endocrinology 2007 195 39-48.
24. Perraudin V, Delarue C, Lefebvre H, Do Rego JL, Vaudry H & Kuhn JM. Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. Journal of Clinical Endocrinology and Metabolism 2006 91 1566-1572.
25. Cartier D, Jegou S, Parmentier F, Lihrmann I, Louiset E, Kuhn JM, Bastard C, Plouin PF, Godin M, Vaudry H & Lefebvre H. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. European Journal of Endocrinology 2005 153 939-947.
26. Lefebvre H, Gonzalez KN, Contesse V, Delarue C, Vaudry H & Kuhnl JM. Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers. Endocrine Research 1998 24 749-752.
27. Lefebvre H, Cartier D, Duparc C, Lihrmann I, Contesse V, Delarue C, Godin M, Fischmeister R, Vaudry H & Kuhn JM. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 2002 87 1211-1216.
28. Reincke M, Beuschlein F, Menig G, Hofmockel G, Arlt W, Lehmann R, Karl M & Allolio B. Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. Journal of Endocrinology 1998 156 415-423.
29. Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B & Reincke M. Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms. Clinical Endocrinology 2001 54 627-632.
30. Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M & Demura H. Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism 1992 75 323-327.
31. Ganguly A, Pratt JH, Weinberger MH, Grim CE & Fineberg NS. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism 1983 57 388-392.
32. Lefebvre H, Contesse V, Delarue C, Vaudry H & Kuhn JM. Serotonergic regulation of adrenocortical function. Hormone and Metabolic Research 1998 30 398-403.
33. Perraudin V, Delarue C, Lefebvre H, Contesse V, Kuhn JM & Vaudry H. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. Journal of Clinical Endocrinology and Metabolism 1993 76 1522-1528.
34. Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Cote M, Payet MD, Manzoni O, Barberis C, Robert M & Gallo-Payet N. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology 1995 136 1285-1295.
35. Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, Suwa T, Hanafusa J, Daido H, Morita H & Yasuda K. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2002 87 5706-5713.
36. Coslovsky R, Wajchenberg BL & Nogueira O. Hyperresponsiveness to lysine-vasopressin in Cushing's disease. Acta Endocrinologica 1974 75 125-132.
37. Gallo-Payet N & Guillon G. Regulation of adrenocortical function by vasopressin. Hormone and Metabolic Research 1998 30 360-367.
38. Schorr I & Ney RL. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase. Journal of Clinical Investigation 1971 50 1295-1300.
39. Matsukura S, Kakita T, Sueoka S, Yoshimi H, Hirata Y, Yokota M & Fujita T. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Cancer Research 1980 40 3768-3771.
40. Dutton CM, Joba W, Spitzweg C, Heufelder AE & Bahn RS. Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid 1997 7 879-884.